propafenone

(redirected from Rythmol)

propafenone

 [pro″pah-fe´nōn]
a sodium channel blocking agent that acts on the Purkinje fibers and the myocardium; used as the hydrochloride salt in treatment of life-threatening arrhythmias, administered orally.

propafenone

/pro·pa·fe·none/ (pro″pah-fe´nōn) a sodium channel blocking agent acting on the Purkinje fibers and the myocardium; used as the hydrochloride salt as an antiarrhythmic.

propafenone

Rythmol® Cardiology A beta-blocking antiarrhythmic for severe ventricular and supraventricular arrhythmias–A Fib, V Tach, conduction block, HTN Complications Ventricular proarrhythmia; conduction defects Adverse effects Neurologic–headache, dizziness, paresthesias, peripheral neuropathy, GI–eg, N&V, anorexia. See Antiarrhythmic, Beta-blockers.

propafenone

A drug used to treat heart irregularities (arrhythmias). A brand name is Arythmol.

propafenone (prō´pəfē´nōn),

n brand name: Rythmol;
drug class: antidysrhythmic (Class IC);
action: able to slow conduction velocity; reduces cardiac muscle membrane responsiveness; inhibits automaticity; increases ratio of effective refractory period to action potential duration; β-blocking activity;
use: documented life-threatening dysrhythmias.
References in periodicals archive ?
received final approval for propafenone hydrochloride extended-release capsules USP, 225 mg, 325 mg and 425 mg, the generic version of GlaxoSmithKline PLC's Rythmol SR.
M2 EQUITYBITES-September 11, 2017-Glenmark Pharmaceuticals granted final FDA approval to market generic version of Rythmol SR
M2 PHARMA-September 11, 2017-Glenmark Pharmaceuticals granted final FDA approval to market generic version of Rythmol SR
It also launched Propafenone Hydrochloride extended-release capsules, the generic of GlaxoSmithKline's Rythmol capsules.
On January 3, 2011, Par Pharmaceutical successfully launched the 225mg, 325mg, and 425mg strengths of propafenone SR capsules, the generic version of GlaxoSmithKline's Rythmol SR [R] .
Linde predicted that if the new REVERSE findings are confirmed in the much larger ongoing Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy (MADIT-CRT) trial and Rythmol SR Atrial Fibrillation Trial (RAFT), as she expects, the indications for CRT will broaden to incorporate the large population of patients with class I and II heart failure.
My blood pressure and cholesterol are in a healthy range and I have experienced no AFib manifestations since beginning a medication regimen that includes Rythmol.
for infringement of United States Patent 5,681,588, which expires in 2014 and relates to Reliant's Rythmol SR product.
GlobalData's pharmaceuticals report, Rythmol SR (Atrial Fibrillation) - Analysis and Forecasts to 2022 provides Rythmol SR global sales estimates.
M2 EQUITYBITES-June 2, 2016-Mylan announces generic Rythmol Sustained-Release Capsules in 225 mg, 325 mg, 425 mg in the US market
M2 PHARMA-June 2, 2016-Mylan announces generic Rythmol Sustained-Release Capsules in 225 mg, 325 mg, 425 mg in the US market
Reliant Pharmaceuticals, LLC (Liberty Corner, NJ), a privately held, rapidly growing pharmaceutical company that markets branded, patent-protected pharmaceutical products in the United States, announced that it has signed a definitive agreement to acquire the United States rights to the Rythmol (propafenone HCl) product family from Abbott Laboratories.